z-logo
Premium
Regeneration of lingual musculature in rats using myoblasts over porcine bladder acellular matrix
Author(s) -
CamachoAlonso Fabio,
GarcíaCarrillo Nuria,
Buendía Antonio Julián,
Navarro Jose Antonio,
PeñarrochaOltra David,
PeñarrochaDiago Miguel,
LacalLuján Jose
Publication year - 2021
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.13674
Subject(s) - myocyte , desmin , regeneration (biology) , tongue , anatomy , medicine , immunohistochemistry , muscle tissue , pathology , biology , microbiology and biotechnology , vimentin
Objectives To use tissue engineering muscle repair (TEMR) for regenerating the lingual musculature of hemiglossectomized rats using neonatal myoblasts (NM) on porcine acellular urinary bladder matrix (AUBM). Material and Methods The study used 80 male rats. A volumetric muscle loss (VML) injury was created on the left side of the tongue. The rats were randomized into four groups: Group 1 (AUBM + myoblasts); Group 2 (AUBM); Group 3 (myoblasts); and Group 4 (control). NM were obtained from neonatal rats. The animals were weighed on day 0 and just before euthanasia. Five rats in each group were euthanized at days 2, 14, 28, and 42; the tongues were prepared for morphometric analysis, postoperative left hemitongue weight, and immunohistochemical analysis (desmin, CD‐31, and anti‐neurofilament). Results The weight gain from greatest to least was as follows: AUBM + myoblasts > myoblasts > AUBM > control. The tongue dorsum occupied by VML, and difference in mg between control side and intervened side from least to great was as follows: AUBM + myoblasts < myoblasts < AUBM < control. The order from highest to lowest antibody positivity was as follows: AUBM + myoblasts > myoblasts > AUBM > control. Conclusion The use of porcine AUBM and NM for the regeneration of lingual musculature was found to be an effective TEMR treatment for repairing tongue VML injury.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here